AbbVie (ABBV) Receives Positive CHMP Opinion for Venclyxto as CLL Treatment
Go back to AbbVie (ABBV) Receives Positive CHMP Opinion for Venclyxto as CLL Treatment| AbbVie (NYSE: ABBV) | Delayed: 167.08 -0.72 (0.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $167.80 | 52 Week High | $68.12 | |||
| Open | $167.66 | 52 Week Low | $50.71 | |||
| Day High | $169.29 | P/E | 36.24 | |||
| Day Low | $165.57 | EPS | $4.61 | |||
| Volume | 2,321,755 | |||||
